Veterinary Medicines

Finilac 50 mcg/ml

Authorised
  • Cabergoline
Download as PDF

Product identification

Medicine name:
Finilac 50 mcg/ml
Finilac 50 µg/ml Drank
Finilac 50 µg/ml Solution buvable
Finilac 50 µg/ml Lösung zum Einnehmen
Active substance:
  • Cabergoline
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Cabergoline
    50.00
    microgram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral solution
Withdrawal period by route of administration:
  • Oral use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QG02CB03
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Package description:
  • Cardboard box containing 1 bottle (brown type-III glass, closed by a LDPE conical Luer slip syringe adapter and a HDPE screw cap) filled with 25 ml
  • Cardboard box containing 1 bottle (brown type-III glass, closed by a LDPE conical Luer slip syringe adapter and a HDPE screw cap) filled with 3 ml
  • Cardboard box containing 1 bottle (brown type-III glass, closed by a LDPE conical Luer slip syringe adapter and a HDPE screw cap) filled with 10 ml
  • Cardboard box containing 1 bottle (brown type-III glass, closed by a LDPE conical Luer slip syringe adapter and a HDPE screw cap) filled with 50 ml
  • Cardboard box containing 1 bottle (brown type-III glass, closed by a LDPE conical Luer slip syringe adapter and a HDPE screw cap) filled with 15 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Dechra Regulatory B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Dreluso Pharmazeutika Dr. Elten Und Sohn GmbH
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V473200
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0188/001
Concerned member states:
  • Austria
  • Belgium
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/03/2022
Download
French (PDF)
Published on: 22/03/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/03/2022
Download
French (PDF)
Published on: 22/03/2022
Download
German (PDF)
Published on: 22/03/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."